{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:10:29Z","timestamp":1791090629219,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T00:00:00Z","timestamp":1394582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00280-014-2422-z","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T17:51:36Z","timestamp":1394560296000},"page":"919-923","source":"Crossref","is-referenced-by-count":76,"title":["Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy"],"prefix":"10.1007","volume":"73","author":[{"given":"Marta","family":"Sim\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas A.","family":"Argyriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Maci\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Plans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Maj\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Bruna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,12]]},"reference":[{"issue":"Suppl 5","key":"2422_CR1","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nos218","volume":"14","author":"TA Dolecek","year":"2012","unstructured":"Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005\u20132009. Neuro-Oncology 14(Suppl 5):v1\u2013v49","journal-title":"Neuro-Oncology"},{"issue":"3","key":"2422_CR2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"J Wiemels","year":"2010","unstructured":"Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99(3):307\u2013314","journal-title":"J Neurooncol"},{"issue":"6","key":"2422_CR3","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1227\/01.NEU.0000188281.91351.B9","volume":"57","author":"EB Claus","year":"2005","unstructured":"Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM (2005) Epidemiology of intracranial meningioma. Neurosurgery 57(6):1088\u20131095","journal-title":"Neurosurgery"},{"issue":"2","key":"2422_CR4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1440-1789.2007.00750.x","volume":"27","author":"J Bruna","year":"2007","unstructured":"Bruna J, Brell M, Ferrer I, Gimenez-Bonafe P, Tortosa A (2007) Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathology 27(2):114\u2013120","journal-title":"Neuropathology"},{"issue":"2","key":"2422_CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.critrevonc.2008.01.010","volume":"67","author":"C Marosi","year":"2008","unstructured":"Marosi C, Hassler M, Roessler K, Reni M, Sant M, Mazza E, Vecht C (2008) Meningioma. Crit Rev Oncol Hematol 67(2):153\u2013171","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"2422_CR6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","volume":"99","author":"C Mawrin","year":"2010","unstructured":"Mawrin C, Perry A (2010) Pathological classification and molecular genetics of meningiomas. J Neurooncol 99(3):379\u2013391","journal-title":"J Neurooncol"},{"issue":"10","key":"2422_CR7","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1586\/ern.11.38","volume":"11","author":"MC Chamberlain","year":"2011","unstructured":"Chamberlain MC, Barnholtz-Sloan JS (2011) Medical treatment of recurrent meningiomas. Expert Rev Neurother 11(10):1425\u20131432","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"2422_CR8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clineuro.2009.12.011","volume":"112","author":"GA Alexiou","year":"2010","unstructured":"Alexiou GA, Gogou P, Markoula S, Kyritsis AP (2010) Management of meningiomas. Clin Neurol Neurosurg 112(3):177\u2013182","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"2422_CR9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/CCO.0b013e328356364d","volume":"24","author":"MC Chamberlain","year":"2012","unstructured":"Chamberlain MC (2012) The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma. Curr Opin Oncol 24(6):666\u2013671","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"2422_CR10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11060-010-0349-8","volume":"99","author":"PY Wen","year":"2010","unstructured":"Wen PY, Quant E, Drappatz J, Beroukhim R, Norden AD (2010) Medical therapies for meningiomas. J Neurooncol 99(3):365\u2013378","journal-title":"J Neurooncol"},{"issue":"8 Suppl 1","key":"2422_CR11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0026-0495(96)90098-0","volume":"45","author":"SW Lamberts","year":"1996","unstructured":"Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ (1996) Somatostatin analogs: future directions. Metabolism 45(8 Suppl 1):104\u2013106","journal-title":"Metabolism"},{"issue":"1\u20132","key":"2422_CR12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/B:NEON.0000013498.19981.55","volume":"66","author":"S Arena","year":"2004","unstructured":"Arena S, Barbieri F, Thellung S, Pirani P, Corsaro A, Villa V, Dadati P, Dorcaratto A, Lapertosa G, Ravetti JL, Spaziante R, Schettini G, Florio T (2004) Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity. J Neurooncol 66(1\u20132):155\u2013166","journal-title":"J Neurooncol"},{"issue":"4","key":"2422_CR13","first-page":"237","volume":"37","author":"PP Garc\u00eda-Luna","year":"1993","unstructured":"Garc\u00eda-Luna PP, Relimpio F, Pumar A, Pereira JL, Leal-Cerro A, Trujillo F, Cort\u00e9s A, Astorga R (1993) Clinical use of octreotide in unresectable meningiomas. A report of three cases. J Neurosurg Sci 37(4):237\u2013241","journal-title":"J Neurosurg Sci"},{"issue":"1","key":"2422_CR14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0303-8467(97)00110-8","volume":"100","author":"ML Jaffrain-Rea","year":"1998","unstructured":"Jaffrain-Rea ML, Minniti G, Santoro A, Bastianello S, Tamburrano G, Gulino A, Cantore G (1998) Visual improvement during octreotide therapy in a case of episellar meningioma. Clin Neurol Neurosurg 100(1):40\u201343","journal-title":"Clin Neurol Neurosurg"},{"issue":"10","key":"2422_CR15","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1212\/01.wnl.0000271382.62776.b7","volume":"69","author":"MC Chamberlain","year":"2007","unstructured":"Chamberlain MC, Glantz MJ, Fadul CE (2007) Recurrent meningioma: salvage therapy with long-acting somatostatin analogue. Neurology 69(10):969\u2013973","journal-title":"Neurology"},{"issue":"5","key":"2422_CR16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/neuonc\/nor044","volume":"13","author":"DR Johnson","year":"2011","unstructured":"Johnson DR, Kimmel DW, Burch PA, Cascino TL, Giannini C, Wu W, Buckner JC (2011) Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma. Neuro-Oncology 13(5):530\u2013535","journal-title":"Neuro-Oncology"},{"key":"2422_CR17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.6004\/jnccn.2011.0036","volume":"9","author":"SS Brem","year":"2011","unstructured":"Brem SS, Bierman PJ, Brem H, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Fine HA, Friedman A, Glass J, Grossman SA, Heimberger AB, Junck L, Levin V, Loeffler JJ, Maor MH, Narayana A, Newton HB, Olivi A, Portnow J, Prados M, Raizer JJ, Rosenfeld SS, Shrieve DC, Sills AK Jr, Spence AM, Vrionis FD (2011) Central nervous system cancers: clinical practice guidelines in oncology. J Natl Compr Cancer Netw 9:352\u2013400","journal-title":"J Natl Compr Cancer Netw"},{"issue":"5","key":"2422_CR18","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3171\/jns.1997.86.5.0840","volume":"86","author":"UM Schrell","year":"1997","unstructured":"Schrell UM, Rittig MG, Anders M, Koch UH, Marschalek R, Kiesewetter F, Fahlbusch R (1997) Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. J Neurosurg 86(5):840\u2013844","journal-title":"J Neurosurg"},{"key":"2422_CR19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/B:NEON.0000021827.85754.8e","volume":"67","author":"D Loven","year":"2004","unstructured":"Loven D, Hardoff R, Sever ZB, Steinmetz AP, Gornish M, Rappaport ZH, Fenig E, Ram Z, Sulkes A (2004) Nonresectable slow-growing meningiomas treated by hydroxyurea. J Neurooncol 67:221\u2013226","journal-title":"J Neurooncol"},{"issue":"3","key":"2422_CR20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s11060-011-0541-5","volume":"104","author":"MC Chamberlain","year":"2011","unstructured":"Chamberlain MC, Johnston SK (2011) Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series. J Neurooncol 104(3):765\u2013771","journal-title":"J Neurooncol"},{"issue":"2","key":"2422_CR21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11060-011-0741-z","volume":"107","author":"MC Chamberlain","year":"2012","unstructured":"Chamberlain MC (2012) Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma. J Neurooncol 107(2):315\u2013321","journal-title":"J Neurooncol"},{"issue":"6","key":"2422_CR22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jnci\/95.6.437","volume":"95","author":"Z Marschall von","year":"2003","unstructured":"von Marschall Z, Scholz A, Cramer T, Sch\u00e4fer G, Schirner M, Oberg K, Wiedenmann B, H\u00f6cker M, Rosewicz S (2003) Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. J Natl Cancer Inst 95(6):437\u2013448","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"2422_CR23","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/cncr.23803","volume":"113","author":"MC Chamberlain","year":"2008","unstructured":"Chamberlain MC, Glantz MJ (2008) Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas. Cancer 113(8):2146\u20132151","journal-title":"Cancer"},{"issue":"1\u20132","key":"2422_CR24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.mce.2008.02.002","volume":"286","author":"S Pyronnet","year":"2008","unstructured":"Pyronnet S, Bousquet C, Najib S, Azar R, Laklai H, Susini C (2008) Antitumor effects of somatostatin. Mol Cell Endocrinol 286(1\u20132):230\u2013237","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2422_CR25","first-page":"1865","volume":"6","author":"S Schulz","year":"2000","unstructured":"Schulz S, Pauli SU, Schulz S, H\u00e4ndel M, Dietzmann K, Firsching R, H\u00f6llt V (2000) Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin Cancer Res 6(5):1865\u20131874","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2422_CR26","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1073\/pnas.91.6.2315","volume":"91","author":"L Buscail","year":"1994","unstructured":"Buscail L, Delesque N, Est\u00e8ve JP, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GI, Liebow C, Schally AV, Vaysse N, Susini C (1994) Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci USA 91(6):2315\u20132319","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2422_CR27","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/2011.1.FOCUS111","volume":"30","author":"C Schulz","year":"2011","unstructured":"Schulz C, Mathieu R, Kunz U, Mauer UM (2011) Treatment of unresectable skull base meningiomas with somatostatin analogs. Neurosurg Focus 30(5):E11","journal-title":"Neurosurg Focus"},{"key":"2422_CR28","doi-asserted-by":"crossref","unstructured":"Kaley T, Barani I, Chamberlain M, McDermott M, Panageas K, Raizer J, Rogers L, Schiff D, Vogelbaum M, Weber D, Wen P (2014) Historical benchmarks for medical therapy trials in surgery-and radiation-refractory meningioma: RANO review. Neuro-Oncology (in press)","DOI":"10.1093\/neuonc\/not330"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2422-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-014-2422-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2422-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T11:00:42Z","timestamp":1565262042000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-014-2422-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,12]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["2422"],"URL":"https:\/\/doi.org\/10.1007\/s00280-014-2422-z","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,12]]}}}